Home/Filings/4/0000899243-22-018808
4//SEC Filing

BEVERIDGE, ROY A 4

Accession 0000899243-22-018808

CIK 0001571498other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:20 PM ET

Size

7.8 KB

Accession

0000899243-22-018808

Insider Transaction Report

Form 4
Period: 2022-05-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-17+41,00641,006 total
    Exercise: $0.56Exp: 2032-05-16Common Stock (41,006 underlying)
  • Award

    Common Stock, par value $0.0001

    2022-05-17+8,99437,109 total
Footnotes (2)
  • [F1]Consists of shares of Common Stock issuable under 8,994 restricted stock units ("RSUs") granted on May 17, 2022, which RSUs are scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. Each RSU represents the right to receive one share of Common Stock upon vesting. In the event of a change in control of the Issuer, the RSUs will vest in full.
  • [F2]This option was granted on May 17, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001579300

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:20 PM ET
Size
7.8 KB